Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Galvis

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Archivos De La Sociedad Espanola De Oftalmologia|October 2, 2018
Antibiotic resistance profile in eye infections in a reference centre in Floridablanca, ColombiaV Galvis, M M Parra, A Tello, et al.
Archivos De La Sociedad Espanola De Oftalmologia|April 24, 2023
Plasma rich in growth factors membrane as a macular hole treatment in a vitrectomized patient due to rhegmatogenous retinal detachmentC M Rangel Gualdrón, V Galvis Ramírez, J D Arias Aristizabal, et al.
Journal for Immunotherapy of Cancer|October 26, 2016
High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcomeS Chow, V Galvis, M Pillai, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Archivos De La Sociedad Espanola De Oftalmologia|October 2, 2018
Antibiotic resistance profile in eye infections in a reference centre in Floridablanca, ColombiaV Galvis, M M Parra, A Tello, et al.
Archivos De La Sociedad Espanola De Oftalmologia|April 24, 2023
Plasma rich in growth factors membrane as a macular hole treatment in a vitrectomized patient due to rhegmatogenous retinal detachmentC M Rangel Gualdrón, V Galvis Ramírez, J D Arias Aristizabal, et al.
Journal for Immunotherapy of Cancer|October 26, 2016
High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcomeS Chow, V Galvis, M Pillai, et al.
Pageof 3